August 12, 2026
Beyang Therapeutics
Beyang Therapeutics raised nearly $30 million in an oversubscribed Series A financing round to advance its AI-powered drug discovery platform.
- Round
- Series A
- Amount raised
- $30M
- Lead investor
- —
- Industry
- AI Drug Discovery, Biotech
- Headquarters
- United States
- Employees
- —
- Website
- —
- —
Source: Beyang Therapeutics